Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of precision genetic medicine to treat rare diseases. It specializes in gene therapy, RNA-targeted exon skipping, and gene editing.The staff at Sarepta Therapeutics come from unusually diverse demographic backgrounds. The company is 56.4% female and 34.1% ethnic minorities. Despite its diversity in other areas, Sarepta Therapeutics employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 75.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party. Sarepta Therapeutics has great employee retention with staff members usually staying with the company for 5.0 years.The average employee at Sarepta Therapeutics makes $94,985 per year, which is competitive for its industry and location. Some of its highest paying competitors, Gilead Sciences, Vertex Pharmaceuticals, and Medivation, pay $99,828, $95,952, and $94,135, respectively.Sarepta Therapeutics is a medium health care company with 840 employees and an annual revenue of $933.0M that is headquartered in Cambridge, MA.
Sarepta Therapeutics's Mission Statement
To engineer precision genetic medicine for rare diseases that devastate lives and cut futures short.
5.0/5
Sarepta Therapeutics employee reviews
Based on 2 ratings
Do you work at Sarepta Therapeutics?
Help job seekers learn about working at Sarepta Therapeutics
Work At Sarepta Therapeutics? Share your experience.
Employee Reviews
5.0
A zippia user wrote a review on Jul 2023
Pros of working at Sarepta Therapeutics
The science, people, company.
Cons of working at Sarepta Therapeutics
Too far, time lines unrealistic
Sarepta Therapeutics Benefits
Salary, benefits
Is this useful?
The team at Sarepta Therapeutics
The founders of Sarepta Therapeutics is Marwan Fawaz.
The key people at Sarepta Therapeutics are Douglas S. Ingram and Marwan Fawaz.
Key People
Douglas S. Ingram
Marwan Fawaz
Sarepta Therapeutics Rankings
Sarepta Therapeutics is ranked #62 on the Best Health Care Companies to Work For in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
The average a Sarepta Therapeutics salary in the United States is $94,985 per year.
Sarepta Therapeutics employees in the top 10 percent can make over $172,000 per year,
while Sarepta Therapeutics employees at the bottom 10 percent earn less than $52,000 per year.
Average Sarepta Therapeutics Salary
$94,985
yearly
$45.67 hourly
Updated March 14, 2024
Evaluate Sarepta Therapeutics' commitment to diversity and inclusion.
Sarepta Therapeutics diversity
9.3
Diversity Score
We calculated Sarepta Therapeutics’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Sarepta Therapeutics’s workforce.
Sarepta Therapeutics diversity summary. Zippia estimates Sarepta Therapeutics's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Sarepta Therapeutics's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Sarepta Therapeutics's workforce.
Sarepta Therapeutics has 840 employees.
56% of Sarepta Therapeutics employees are women, while 44% are men.
The most common ethnicity at Sarepta Therapeutics is White (66%).
13% of Sarepta Therapeutics employees are Asian.
12% of Sarepta Therapeutics employees are Hispanic or Latino.
The average employee at Sarepta Therapeutics makes $94,985 per year.
Sarepta Therapeutics employees are most likely to be members of the democratic party.
Employees at Sarepta Therapeutics stay with the company for 5.0 years on average.
Do you work at Sarepta Therapeutics?
Is Sarepta Therapeutics' workforce diverse and inclusive?
Sarepta Therapeutics Financial Performance
10.0
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Sarepta Therapeutics currently has 933.0M in revenue. Sarepta Therapeutics's most recent quarter produced 309.3m (q3'2023).
Sarepta Therapeutics annual revenue
$933M
$746M
$560M
$373M
$187M
$0
2017
2018
2019
2020
2021
2022
Highest paying Sarepta Therapeutics competitors
Compare Sarepta Therapeutics salaries to competitors, including Gilead Sciences, Vertex Pharmaceuticals, and Medivation. Employees at Gilead Sciences earn the highest average yearly salary of $99,828. The salaries at Vertex Pharmaceuticals average $95,952 per year, and the salaries at Medivation come in at $94,135 per year.
Zippia gives an in-depth look into the details of Sarepta Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sarepta Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Sarepta Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sarepta Therapeutics. The data presented on this page does not represent the view of Sarepta Therapeutics and its employees or that of Zippia.
Sarepta Therapeutics may also be known as or be related to Sarepta Therapeutics, Sarepta Therapeutics Inc, Sarepta Therapeutics Inc. and Sarepta Therapeutics, Inc.